E-drug: New Oxfam papers
-------------------------------------------------------------------------
Beyond Philanthropy: the pharmaceutical industry, corporate social
responsibility and the developing world
by Oxfam, Save the Children and VSO.
Beyond Philanthropy argues that the pharmaceutical industry should do more
to actively consider the needs of poor people in developing countries in
their core business activities. In summary, the report addresses
pharmaceutical companies' corporate social responsibility policies in
relation to the ongoing public debate over access to medicines in the
developing world. It sets out benchmarks in five areas of company policy:
pricing, patents, joint public private partnerships and appropriate use of
medicines.
http://www.oxfam.org.uk/whatnew/press/beyondphil.htm
http://www.oxfam.org.uk/policy/papers/beyphil/beyphil.htm
Hard copies also available.
Just launched: False hope or new start? The Global Fund to Fight HIV/AIDS,
TB, and Malaria. To read this paper please go to:
http://www.oxfam.org.uk/policy/papers/24globalfund/24globalfund.html
-------------------------------------
We have the chance to lift millions out of poverty. Only one thing is
missing -- you.
Please join the Oxfam trade campaign at http://www.maketradefair.com
Oxfam works with others to find lasting solutions to poverty and suffering.
Oxfam GB is a member of Oxfam International, a company limited by guarantee
and registered in England No. 612172.
Registered office: 274 Banbury Road, Oxford OX2 7DZ.
Registered charity No. 202918.
Visit the web site at http://www.oxfam.org.uk
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html